Ablate and Pace HIS Study

Recruiting now · Not applicable

Conditions studied: HIS Bundle Pacing, Atrial Fibrillation

In brief

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and estimates suggest its prevalence is increasing. Despite the advances in AF ablation strategies, the outcome of ablation procedures in persistent AF is still unsatisfactory. In addition, many patients are not candidates for ablation due to advanced age, comorbidities and previous failed ablation procedures. It is well known that there is no mortality benefit from rhythm versus rate control strategy in AF, therefore the increased number of AV node ablation and pacemaker insertion for patients with symptomatic AF with uncontrolled heart rate. Following AV node ablation, it is understandable that these patients will be paced 100% of the time where the value of physiological pacing will be at its most. The current standard practice is to pace the right ventricle for this cohort of patients unless they have severe LV systolic dysfunction when a biventricular pacing might be recommended. Previous data showed that RV pacing only can lead to deterioration of LV function, worsening of heart failure symptoms and increased mortality. HIS bundle pacing is a novel technique of pacing through placing the pacemaker lead on the junction box between the top and bottom chamber of the heart. This will allow the utilisation of the normal/intrinsic HIS Purkinjie (eclectic cables) to stimulate the ventricles. This can offer a physiological pacing modality and reduce pacing induced cardiomyopathy specially in pacing dependent pacing. The Ablate and Pace HIS Study proposes that the new method of HIS pacing is safe, effective and superior to the existing method of RV pacing in patients with atrial fibrillation who demonstrate signs of heart failure.

Key facts

Study ID: NCT06152406
Run by: University Hospitals, Leicester
People needed: 100
Starts: 2023-10-24
Expected to finish: 2028-02-29
Last updated by the study team: 2026-01-05

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Aged 18 or above
Symptomatic AF, New York Heart Association (NYHA) class II-IV
Willing to consent for the study
AF regardless type, deemed not suitable for rhythm control strategy that has been referred for AVN ablation with one of the following:
Impaired LV function, EF <50 %. And or
Raised N-Terminal Pro B-type Natriuretic Peptide ( NT-ProBNP) >365 ng/L

You may not qualify if…

Patient who has already got a pacemaker in situ
Known severe LVSD when biventricular device is the thought to be the preferred pacing modality
Females in child bearing period
Lack of capacity to consent
Other serious medical condition with life expectancy of less than 1 year
Less than 18 years
Unwilling to consent for the study

Where it is running

University Hospitals of Leicester NHS Trust — Leicester, Leicestershire, United Kingdom (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.